Are Infliximab and Adalimumab Equally Effective in Crohn Disease? - study

Summary of a cohort study: www.jwatch.org/na34229/2014/04/23/are-infliximab-and-adalimumab-equally-effective-crohn

Comment at the end of the article:
"These data support the current general impression among clinicians that infliximab and adalimumab have equal efficacy. Physicians and patients might choose initial therapy based on cost or convenience of therapy, although in some reports, switching patients in remission from infliximab to adalimumab has been associated with loss of response - See more at: http://www.jwatch.org/na34229/2014/04/23/are-infliximab-and-adalimumab-equally-effective-crohn#sthash.V8vZaN0A.dpuf"